Cambridge Epigenetix
Aurel Negrea is a seasoned scientific professional with extensive experience in molecular biology, assay development, and synthetic biology. Currently serving as a Staff Scientist at biomodal since January 2022, Aurel specializes in multiomic solutions for accessing genetic and epigenetic sequence data. Prior roles include Senior Scientist positions at Nuclera, focusing on enzymatic DNA synthesis, and Base4, specializing in molecular biology and Next-Generation Sequencing. Aurel's background also includes a Scientist role in preclinical vaccine research at Novartis Institutes for BioMedical Research, as well as postdoctoral research on infectious diseases at Stockholm University and a PhD in antibiotics related to Salmonella at Karolinska Institutet.
This person is not in any offices
Cambridge Epigenetix
Cambridge Epigenetix (CEGX) is a life sciences tools and analytics company that has created a technology platform delivering step changes in both the type of information that can be generated from DNA and the cost at which it is gathered.